Browse by Medical Category
Frequently asked questions
Request an appointment online
Fatty Liver Clinic: Clinical Trials
The MGH Liver Clinic currently has several studies to monitor the progress of patients with fatty liver disease.
It remains unknown why some people develop fatty liver, and why some develop advanced disease while others do not. The Non-Alcoholic Fatty Liver Disease Repository follows patients every 6 months when they come for their regularly scheduled appointments and monitors their liver disease and response to treatment.
Ongoing clinical trials for non-alcoholic steatohepatitis: Actively recruiting
Non-Alcoholic Fatty Liver Disease
The Study of Biomarkers in Non-Alcoholic Fatty Liver Disease
To better understand why and how non-alcoholic Fatty Liver Disease develops, patients with fatty liver can choose to donate blood to allow for the study of relevant genes, environmental and lifestyle factors. Participation entails up to four 10 mL blood samples. Reimbursement for parking is provided.
Basic eligibility criteria:
Any patient with either abnormal liver function tests or fatty liver seen on ultrasound, CT scan or MRI is eligible.
Kathleen Corey, MD, MPH
Yuri Choi; 617-726-3670
CENTAUR - Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis
Jenna Gustafson; 617-726-3670
The purpose of this study is to better understand how the body’s natural growth hormone levels contribute to the development of non-alcoholic fatty liver disease. Participants in this study will undergo a CT scan, MRI scan and special blood testing. Compensation includes $300 for two visits as well as parking reimbursement.
Individuals with NAFLD ages 18-65 years old.
Karen Miller, MD
Ariana Riccio; 617-726-2764
Back to Top